163 related articles for article (PubMed ID: 19846751)
1. Functional analysis and theoretical modeling of ferroportin reveals clustering of mutations according to phenotype.
Wallace DF; Harris JM; Subramaniam VN
Am J Physiol Cell Physiol; 2010 Jan; 298(1):C75-84. PubMed ID: 19846751
[TBL] [Abstract][Full Text] [Related]
2. Impact of D181V and A69T on the function of ferroportin as an iron export pump and hepcidin receptor.
Praschberger R; Schranz M; Griffiths WJ; Baumgartner N; Hermann M; Lomas DJ; Pietrangelo A; Cox TM; Vogel W; Zoller H
Biochim Biophys Acta; 2014 Sep; 1842(9):1406-12. PubMed ID: 24859227
[TBL] [Abstract][Full Text] [Related]
3. G80S-linked ferroportin disease: classical ferroportin disease in an Asian family and reclassification of the mutant as iron transport defective.
McDonald CJ; Wallace DF; Ostini L; Bell SJ; Demediuk B; Subramaniam VN
J Hepatol; 2011 Mar; 54(3):538-44. PubMed ID: 21094556
[TBL] [Abstract][Full Text] [Related]
4. Impaired iron transport activity of ferroportin 1 in hereditary iron overload.
McGregor JA; Shayeghi M; Vulpe CD; Anderson GJ; Pietrangelo A; Simpson RJ; McKie AT
J Membr Biol; 2005 Jul; 206(1):3-7. PubMed ID: 16440176
[TBL] [Abstract][Full Text] [Related]
5. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
6. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
7. Iron overload due to mutations in ferroportin.
De Domenico I; Ward DM; Musci G; Kaplan J
Haematologica; 2006 Jan; 91(1):92-5. PubMed ID: 16434376
[TBL] [Abstract][Full Text] [Related]
8. In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations.
Schimanski LM; Drakesmith H; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
Blood; 2005 May; 105(10):4096-102. PubMed ID: 15692071
[TBL] [Abstract][Full Text] [Related]
9. Ferroportin diseases: functional studies, a link between genetic and clinical phenotype.
Détivaud L; Island ML; Jouanolle AM; Ropert M; Bardou-Jacquet E; Le Lan C; Mosser A; Leroyer P; Deugnier Y; David V; Brissot P; Loréal O
Hum Mutat; 2013 Nov; 34(11):1529-36. PubMed ID: 23943237
[TBL] [Abstract][Full Text] [Related]
10. Molecular and clinical correlates in iron overload associated with mutations in ferroportin.
De Domenico I; McVey Ward D; Nemeth E; Ganz T; Corradini E; Ferrara F; Musci G; Pietrangelo A; Kaplan J
Haematologica; 2006 Aug; 91(8):1092-5. PubMed ID: 16885049
[TBL] [Abstract][Full Text] [Related]
11. Functional consequences of ferroportin 1 mutations.
Liu XB; Yang F; Haile DJ
Blood Cells Mol Dis; 2005; 35(1):33-46. PubMed ID: 15935710
[TBL] [Abstract][Full Text] [Related]
12. Reduced iron export associated with hepcidin resistance can explain the iron overload spectrum in ferroportin disease.
Viveiros A; Panzer M; Baumgartner N; Schaefer B; Finkenstedt A; Henninger B; Theurl I; Nachbaur K; Weiss G; Haubner R; Decristoforo C; Tilg H; Zoller H
Liver Int; 2020 Aug; 40(8):1941-1951. PubMed ID: 32450003
[TBL] [Abstract][Full Text] [Related]
13. The dynamics of hepcidin-ferroportin internalization and consequences of a novel ferroportin disease mutation.
Wallace DF; McDonald CJ; Ostini L; Iser D; Tuckfield A; Subramaniam VN
Am J Hematol; 2017 Oct; 92(10):1052-1061. PubMed ID: 28681497
[TBL] [Abstract][Full Text] [Related]
14. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
[TBL] [Abstract][Full Text] [Related]
15. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin.
Drakesmith H; Schimanski LM; Ormerod E; Merryweather-Clarke AT; Viprakasit V; Edwards JP; Sweetland E; Bastin JM; Cowley D; Chinthammitr Y; Robson KJ; Townsend AR
Blood; 2005 Aug; 106(3):1092-7. PubMed ID: 15831700
[TBL] [Abstract][Full Text] [Related]
16. Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin.
Aschemeyer S; Qiao B; Stefanova D; Valore EV; Sek AC; Ruwe TA; Vieth KR; Jung G; Casu C; Rivella S; Jormakka M; Mackenzie B; Ganz T; Nemeth E
Blood; 2018 Feb; 131(8):899-910. PubMed ID: 29237594
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the molecular basis of ferroportin resistance to hepcidin: Structure/function analysis of rare SLC40A1 missense mutations found in suspected hemochromatosis type 4 patients.
Le Tertre M; Ka C; Guellec J; Gourlaouen I; Férec C; Callebaut I; Le Gac G
Transfus Clin Biol; 2017 Nov; 24(4):462-467. PubMed ID: 28826751
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin-induced endocytosis of ferroportin is dependent on ferroportin ubiquitination.
Qiao B; Sugianto P; Fung E; Del-Castillo-Rueda A; Moran-Jimenez MJ; Ganz T; Nemeth E
Cell Metab; 2012 Jun; 15(6):918-24. PubMed ID: 22682227
[TBL] [Abstract][Full Text] [Related]
19. Wild-type and mutant ferroportins do not form oligomers in transfected cells.
Gonçalves AS; Muzeau F; Blaybel R; Hetet G; Driss F; Delaby C; Canonne-Hergaux F; Beaumont C
Biochem J; 2006 Jun; 396(2):265-75. PubMed ID: 16457665
[TBL] [Abstract][Full Text] [Related]
20. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
